Stadler, R. (2006) “Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial”, Acta Oncologica, 45(4), pp. 389–399. doi: 10.1080/02841860600630954.